Design Therapeutics, Inc. (DSGN)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
12. 57
-0.04
-0.3172%
$
853.79M Market Cap
- P/E Ratio
- Div Yield
468,200 Volume
-1.18 Eps
$ 12.61
Previous Close 
Want to track DSGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
DSGN Earnings Reports FAQ
What is the earnings per share (EPS) for DSGN?
The current EPS is -1.18.
What is the company's earnings growth rate?
Design Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Design Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Design Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for DSGN at this time, as Design Therapeutics, Inc has no recent EPS data to calculate it.
